CJEU issues clarification on UK’s pay-for-delay generics ruling

The Court of Justice of the European Union (CJEU) has ruled that pharmaceutical pay-for-delay agreements may violate the Treaty on the Functioning of the European Union (TFEU), in comments passed down on January 30, 2020.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

AG advises CJEU to uphold €94 million pay-for-delay fine

5 June 2020 The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

Big Pharma

Retirees interest group supports California’s pay-for-delay ban

10 March 2020 The AARP has urged the US Court of Appeals for the Ninth Circuit to uphold a newly-formed California law prohibiting the majority of pay-for-delay pharmaceutical settlements.

Americas

Par avoids pay-for-delay suit after court accepts payment was ‘fair’

10 March 2020 A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

More features

AIPPI: Personalised medicine tests the limits in patent law

Ropes & Gray loses 21-attorney group to join rival on growth spree

How 'Boehringer' sets preliminary relief threshold for generics

‘Whose trademark law is AI based on exactly?’: Key questions from Marques

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

CJEU issues clarification on UK’s pay-for-delay generics ruling

More on this story

Editor's picks

Editor's picks

More features